A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

NCT01674712 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

575

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Fixed Combination of Fenofibrate/simvastatin 145/20 mg
DRUG: Simvastatin 20 mg
DRUG: Fenofibrate 145 mg
DRUG: Fixed Combination of Fenofibrate/simvastatin 145/40 mg
DRUG: Simvastatin 40 mg

Sponsor

Abbott